
As GLP-1 drugs reshape consumers’ bodies at unprecedented scale, BoF’s Diana Pearl and Brennan Kilbane examine how fashion and beauty brands are adapting to a profound shift in size, fit and appearance.
Source link
The Debrief | Fashion’s Ozempic Reckoning